Soraya Nouraei Motlagh1, Bahram Nabilou2, Hassan Yusefzadeh3*, Vasim Chalesh4
Aim: The chronic nature of diabetes, which accounts for about 85% to 95% of diabetes and its consequences have made the disease costly. This study aimed to analyze the cost-effectiveness of Type 2 Diabetes screening and determine the most appropriate group for this purpose given cost-effectiveness and economic considerations.
Material and Method: This is a descriptive-analytical study which covered people aged over 30 years who were covered by 4 health centers and 25 health houses. To calculate the cost-effectiveness, the diabetes care and screening costs and the number of avoided DALYs were used. Excel and Treeage software’s were used for data analysis.
Results: without the screening, the number of lost years of life caused by type 2 diabetes was 111.6395 including 0.0395, 22.5, 23.84 and 4.56 years were associated with diabetic foot, neuropathy, nephropathy, and retinopathy respectively. The Incremental Cost-Effectiveness Ratio was estimated as 192,112,395 Rials that compared to threshold defined by the WHO, diabetes screening is cost-effective among the people over the 40 years ages.
Conclusion: The program of type 2 diabetes screening is a cost-effective intervention and could save 111.6395 years of life in the target population. Therefore, the diabetes screening program, as well as beneficial results for patients in the long run, will save money for the society and improve the quality and quantity of life in the affected population. Also, the results of this study can be helpful in allocating resources for diabetes prevention and treatment.
